Clinical trial
Study to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of…
NCT00109772 · Celgene Corporation, Industry · Terminated
Key facts
| NCT number | NCT00109772 |
|---|---|
| Title | Study to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of Complex Regional Pain Syndrome Type 1 |
| Official title | A Multicenter, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of Complex Regional Pain Syndrome Type 1 |
| Acronym | CRPS-002 |
| Lead sponsor | Celgene Corporation, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Complex Regional Pain Syndrome, Type I |
| Intervention type | Drug |
| Interventions | lenalidomide, Placebo |
| Enrollment | 184 |
| Start date | Feb 1, 2005 |
| Primary completion | Apr 1, 2008 |
| Completion | Apr 1, 2008 |
| First posted | May 4, 2005 |
| Last update posted | Aug 28, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: